£5.5M
The seed round was co-led by Montage Ventures and AIX Ventures to fund asset expansion and clinical trials.
Ignota Labs
Ignota Labs uses artificial intelligence to turnaround failed pharmaceutical drugs.
£5.5MTotal raised
Ignota Labs is a Cambridge-based biotechnology firm that applies artificial intelligence and machine learning to turnaround failed drug candidates. Its platform identifies the root causes of drug toxicity to revive abandoned pharmaceutical assets.
Categories
Founders
Sam Windsor
CEO and Co-Founder
Sam is the co-founder and chief executive of Ignota Labs, bringing prior consulting experience from The PSC.
LinkedIn